TradingView
mgiuliani
26 de Jan de 2017 16:06

Johnson & Johnson (JNJ) Viés de alta

Johnson & JohnsonNYSE

Descrição

The acquisition of Actelion for 30 mld dollars is a good strike, the EPS for the 2017 are at 6.60 dollars (1.65 dollars for quarter), this equity has a good yield and bright dividend growth prospects. In our view we think that it is a buy stock, with an interesting dividend yeld of 2.85%
Comentários
mgiuliani
Target reached on 16 Feb.
Position closed.
vaicru
@mgiuliani, hey hey hey , visto che rialzo ?
mgiuliani
ciao, si ha spinto davvero tanto, così come Colgate, anche lì super profitti in pochissimo tempo! @vaicru,
mgiuliani
IMPORTANT:
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
Always make your analysis of your own before your trade.
If you find useful my analysis, please hit the LIKE button and follow me.
Mais